Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting

<p>Abstract</p> <p>Background</p> <p>Non-nucleoside reverse transcriptase inhibitor (NNRTI) with stavudine and lamivudine is widely used as the first-line antiretroviral therapy (ART) in resource-limited settings. Lipodystrophy is common and options for switching ART re...

Full description

Bibliographic Details
Main Authors: Watcharananan Siriorn, Malathum Kumthorn, Apisarnthanarak Anucha, Kiertiburanakul Sasisopin, Sungkanuparph Somnuek, Sathapatayavongs Boonmee
Format: Article
Language:English
Published: BMC 2007-11-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/4/1/26

Internet

http://www.aidsrestherapy.com/content/4/1/26

Similar Items